PTGS2 and colorectal carcinoma: Contursi et al. found that pEVs from colorectal cancer (CRC) patients increase the EMT markers, cyclooxygenase (COX)-2 (PTGS2) expression, and thromboxane (TX) B2 production in CRC cell lines.